PMO Interview with the Innovator Series: Volume 5
Michael Pellini, MD
Video Categories: PMO Interview with the Innovator Series
Michael Pellini, President and Chief Executive Officer of Foundation Medicine, offers a definition of personalized medicine in this new video series from Personalized Medicine in Oncology.
Listen as some of the top academic and community thought leaders in multiple myeloma define what precision medicine means to them.
The publishers of Personalized Medicine in Oncology (PMO) invite you to watch an interview with Peter Hirth, PhD, Chief Executive Officer of Plexxikon. In part one, Dr. Hirth discusses the use of biomarkers, segmenting the population of melanoma patients into subsets, and other aspects of personalized medicine.